VeriMom¿Es di-c12-15 pareth-4 phosphate seguro durante el embarazo?
No harmonised CLP classification (ECHA Annex VI) or SCCS/CIR reproductive hazard listing found for di-C12-15 pareth-4 phosphate. No published reproductive toxicity or human teratogenicity data identified in authoritative reviews; as a surfactant/ethoxylated fatty alcohol phosphate, there is no specific mechanism for reproductive toxicity reported. Dermal cosmetic use gives low but measurable potential for minimal systemic exposure (typical for anionic surfactants), so exposure scored as low. Sources consulted: ECHA Annex VI (no harmonised classification), PubChem/CosIng entries (ingredient identity/uses), literature databases (no specific reproductive studies found).
Pregnancy-safe products containing di-c12-15 pareth-4 phosphate
Related ingredients
Frequently asked questions
- ¿Es di-c12-15 pareth-4 phosphate seguro durante el embarazo?
- No harmonised CLP classification (ECHA Annex VI) or SCCS/CIR reproductive hazard listing found for di-C12-15 pareth-4 phosphate. No published reproductive toxicity or human teratogenicity data identified in authoritative reviews; as a surfactant/ethoxylated fatty alcohol phosphate, there is no specific mechanism for reproductive toxicity reported. Dermal cosmetic use gives low but measurable potential for minimal systemic exposure (typical for anionic surfactants), so exposure scored as low. Sources consulted: ECHA Annex VI (no harmonised classification), PubChem/CosIng entries (ingredient identity/uses), literature databases (no specific reproductive studies found).
- ¿Es di-c12-15 pareth-4 phosphate seguro durante la lactancia?
- Same rationale as pregnancy: no authoritative reproductive/breast‑milk transfer hazards identified. Low but measurable systemic exposure from topical use is possible but no data demonstrating transfer in milk. Sources: ECHA Annex VI, PubChem, CosIng; no SCCS/CIR hazard finding.
- ¿Es di-c12-15 pareth-4 phosphate seguro para la piel del bebé?
- No infant-specific reproductive or developmental toxicity data found. Because infant skin has a higher surface‑area‑to‑weight ratio and an immature barrier, topical exposure was up‑rated by +1 relative to adult exposure (adult e=1 → infant e=2). No evidence indicates increased mechanistic hazard for infants. Sources: CosIng/PubChem for ingredient use and identity; no SCCS/CIR concerns or ECHA harmonised classification.
- ¿Cómo puntúa VeriMom a di-c12-15 pareth-4 phosphate?
- VeriMom puntúa di-c12-15 pareth-4 phosphate en 93/100 (sin riesgos conocidos) según el estado EU CosIng, clasificaciones ECHA y estudios PubMed.
- ¿Cuáles son las alternativas seguras a di-c12-15 pareth-4 phosphate en el embarazo?
- Consulta nuestra lista de alternativas seguras a di-c12-15 pareth-4 phosphate según función similar y clasificación sin riesgos conocidos.
Comprueba cualquier etiqueta en 2 segundos
Descarga VeriMom gratis — escanea cualquier producto y ve la puntuación de seguridad en el embarazo al instante.
Aviso Médico
Esta información es solo para fines educativos y no constituye asesoramiento médico. Las puntuaciones de seguridad se basan en datos disponibles públicamente y pueden no reflejar todos los riesgos. Siempre consulte a su profesional de salud antes de usar cualquier producto durante el embarazo o la lactancia.